Great Point Partners’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-10,746
Closed -$6.89M – 33
2024
Q4
$6.89M Hold
10,746
– – 3.25% 14
2024
Q3
$6.06M Sell
10,746
-2,655
-20% -$1.59M 1.78% 22
2024
Q2
$9.13M Sell
13,401
-184
-1% -$132K 1.75% 22
2024
Q1
$12M Buy
+13,585
New +$7.24M 1.86% 23

Other funds holding JSPR

Great Point Partners's JSPR Position: Q1 2025 in Review

Great Point Partners sold out of Jasper Therapeutics (JSPR) in Q1 2025, closing a stake of 10,746 shares — an estimated $6.89M sold.

Great Point Partners first reported a position in JSPR in Q1 2024 and held it in 4 quarters. The position peaked at $12M in Q1 2024. 67 funds tracked by Wall St. Rank hold JSPR as of Q1 2025.

  • Great Point Partners reported no remaining Jasper Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Great Point Partners sold 10,746 Jasper Therapeutics shares in Q1 2025, an estimated $6.89M.
  • Great Point Partners first reported a position in Jasper Therapeutics in Q1 2024 and held it in 4 quarters.
  • Great Point Partners's Jasper Therapeutics position peaked at $12M in Q1 2024.
  • 67 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2025.

Based on Great Point Partners's 13F filing for Q1 2025, filed 15 May 2025.